Universal earnings date
Universal (UVV) Q2 2027 Earnings Report
DE:UVV Q2 2027 EPS Results
- Actual EPS
- EUR 0.35
- Consensus EPS
- EUR 0.52
- Beat/Miss
- Missed by -EUR 0.17
- One Year Ago EPS
- EUR 1.22
DE:UVV Q2 2027 Revenue Results
- Actual Revenue
- EUR 556.77M
- Expected Revenue
- EUR 564.16M
- Beat/Miss
- Missed by -EUR 7.39M
- YoY Revenue Growth
- -17.55%
Earnings Announcement Details
- Quarter
- Q2 2027
- Date
- 11/04/2026
- Time
- After Close
- Conference Call
- Wednesday, November 4, 2026
Universal's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q2 2027 Earnings Call Audio
Q2 2027 Earnings Slide Deck
Q2 2027 Earnings Call Summary
The call presented a mixed outlook. Current results were significantly weaker, with double-digit revenue declines, lower operating income and net income, an Ingredients operating loss, higher net debt and persistent market and supply challenges. These issues were balanced by management's confidence in second-half tobacco shipments, inventory reduction, potential additional customer demand, expected margin improvement, strong liquidity and ongoing long-term transformation initiatives.
Management expects shipments and financial results to be heavily weighted to the second half, particularly the third and fourth quarters, with uncommitted inventories reducing further from 19% within the target range as of September 30. Gross profit percent of revenue is expected to remain inside the 17% to 19% range, tobacco operating margin is forecast to show some improvement and be comparable with fiscal '26, again within that kind of 17% to 19% range, SG&A is expected to be between $300 million and $310 million, and the $70 million range for interest expense was described as a pretty fair way to see it based on year-to-date interest expense and trend. Additional El Niño-related sales opportunities would be in addition to the sales plan but were not quantified, while working capital usage is expected to moderate, with an aim to delever the balance sheet and reduce interest expense. The Ingredients initiatives are expected to continue through next fiscal year, although management said it is difficult to say exactly how results will play out quarter by quarter.
- Tobacco Commitments and Inventory ProgressCustomer commitments remained in line with the full-year sales plan. Uncommitted inventory declined to 19% as of September 30, within the company's target range, and estimated unsold flue-cured and burley stocks were approximately 134 million kilos, down approximately 45 million kilos from June 30.
- Second-Half Tobacco OutlookManagement expects tobacco shipments and financial results to be heavily weighted to the third and fourth quarters, consistent with historical patterns, and expects uncommitted inventories to reduce further during the second half. Management expressed confidence in the outlook for the balance of the year.
- Potential Additional Tobacco DemandThe company is seeing emerging customer interest in additional tobacco volumes, driven in part by El Niño weather concerns. Management said these could represent sales opportunities in addition to the current sales plan, although the potential volume and timing remain dependent on customer needs, available grades and purchase decisions.
- Tobacco Margin Improvement ExpectedManagement expects some improvement in tobacco operating margin as second-half volumes are shipped. Current forecasts indicate a tobacco operating margin comparable to fiscal 2026 and within the 17% to 19% range. Consolidated gross profit percentage returned to the historical 17% to 19% range in the second quarter and management expects that trend to continue.
- Ingredients Transformation InitiativesUniversal aligned its Ingredients business and leadership around Fruit, Dry and Taste solutions to sharpen commercial focus and support improved facility utilization and operating efficiency. The company is continuing transformation and improvement initiatives, particularly across its extracts and flavor operations, with a focus on commercial execution, capacity utilization, operational efficiency and financial performance.
- Higher Vanilla Extract VolumesVanilla extract sales were higher than the prior year, primarily due to larger volumes, including additional business with existing customers and possibly some new customer business.
- Liquidity AvailabilityAs of September 30, 2026, liquidity availability, including cash and availability under committed and uncommitted credit lines, totaled approximately $945 million.
- Expected Moderation in Working Capital UsageFollowing extraordinarily large crop sizes in fiscal years 2026 and 2027, management expects working capital usage to moderate because of the recent shift to oversupply and expected smaller global crop sizes for the next growing season. The company intends to use this opportunity to delever its balance sheet and reduce interest expense.
- Long-Term Shareholder and Corporate MilestonesUniversal will mark its 100th anniversary as a listed company on the New York Stock Exchange next November and has delivered 56 consecutive years of annual dividend increases.
- Long-Term Strategic PrioritiesThe company's strategy is focused on maximizing and optimizing tobacco, growing Ingredients and strengthening Universal for its next 100 years. Management also cited advancing sustainability programs and expanding the use of artificial intelligence as part of its efforts to improve innovation, efficiency and productivity.
- Brazil Currency BenefitManagement said it is focused on the strength or weakness of the Brazilian real against the U.S. dollar. A weaker real benefits the company because it is dollarized, helping it manage costs and offer more attractive pricing to customers.
- Selling Expense Outlook ReaffirmedManagement confirmed that an annual SG&A range of $300 million to $310 million remains fair.
DE:UVV Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2027 (Q3) | 1.56- | 1.21 | ― | ― |
| Nov 04, 2026 | 2027 (Q2) | 0.520.35 | 1.22 | -71.32% (-0.87) | |
| Aug 05, 2026 | 2027 (Q1) | 0.22-0.18 | 0.34 | -152.63% (-0.52) | |
| May 28, 2026 | 2026 (Q4) | 0.97-0.41 | 0.72 | -157.50% (-1.13) | |
| Feb 09, 2026 | 2026 (Q3) | 1.721.21 | 2.12 | -43.09% (-0.92) | |
| Nov 05, 2025 | 2026 (Q2) | 1.201.22 | 0.92 | 31.78% (+0.29) | |
| Aug 06, 2025 | 2026 (Q1) | ―0.34 | 0.01 | 3700.00% (+0.33) | |
| May 29, 2025 | 2025 (Q4) | ―0.72 | 1.42 | -49.69% (-0.71) | |
| Feb 10, 2025 | 2025 (Q3) | ―2.12 | 1.9 | 11.99% (+0.23) | |
| Nov 12, 2024 | 2025 (Q2) | ―0.92 | 1.01 | -8.19% (-0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


